Trial Profile
A comparative study of the efficacy and tolerability of maintenance treatment of patients with mild/moderate persistent asthma with Asmanex Twisthaler 220 mcg QD PM versus 'Asmanex' placebo QD PM.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Mometasone (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Organon
- 20 Apr 2010 Actual patient number (26) added as reported by ClinicalTrials.gov.
- 22 Aug 2007 Status changed from recruiting to discontinued.
- 10 Apr 2007 New trial record.